Trastuzumab deruxtecan RNA Pull Down Intracellular Accession P33993 Clone Number

Intracellular Accession P33993 Clone Number SDT-062-18 Antibody Type Rabbit mAb Application WB

particularly in combination with other cytokines such as IL-3

with C-terminal 8*His MVPPPENVRMNSVNFKNILQWESPAFAKGNLTFTAQYLSYRIFQDKCMNTTLTECDFSSLSKYGDHTLRVRAEFADEHSDWVNITFCPVDDTIIGPPGMQVEVLADSLHMRFLAPKIENEYETWTMKNVYNSWTYNVQYWKNGTDEKFQITPQYDFEVLRNLEPWTTYCVQVRGFLPDRNKAGEWSEPVCEQTTHDETVPSGGGSHHHHHHHH

Keratin 8 is often used together with keratin 18 and keratin 19 to differentiate cells of epithelial origin from hematopoietic cells in tests that enumerate circulating tumor cells in blood

Trastuzumab deruxtecan RNA Pull Down Intracellular Accession P33993 Clone NumberProduct Specification Antibody Type ADC Concentration 1 mg ml Endotoxin <1EU mg Physical Appearance Liquid Storage Buffer Reconstitute the Trastuzumab deruxtecan using 0. 9% Sodium Chloride Injection Stability & Storage 2 to 8 C for 2 weeks under sterile conditions; 20 C for 3 months under sterile conditions; 80 C for 24 months under sterile conditions. Please avoid repeated freeze thaw cycles. Background Trastuzumab deruxtecan (DS 8201a) is an anti